by Jim Hᴏft Major Big Pharma companies have abruptly halted their latest COVID-19 mRNA “booster” trial because they literally couldn’t find enough willing participants. After years of gaslighting the American public, […]
Big Pharma Forced To Yank COVID Vaxx Study Due To Lack Of Participants
Authored by Ben Sellers via Headline USA, Two of the major pharmaceutical companies connected with the controversial COVID vaccines were forced to abandon a new research study after failing to garner enough participants. Pfizer and German vax maker […]
Characterization of PASC and investigation of biomarkers: Insights from the RECOVER adult cohort
RECOVER researchers shared how biomarkers and the RECOVER-Adult Long COVID Research Index can help researchers understand, diagnose, prevent, and treat Long COVID. During the February 11th RECOVER Research Review (R3) […]
Pharmacologic Management of Long COVID: Mechanisms, Therapeutics, Risks, and Emerging Clinical Trials
John Murphy, CEO, The Covid-Long haul Foundation Abstract Long COVID (Post-Acute Sequelae of SARS-CoV-2 infection, PASC) is a heterogeneous, multi-system disorder characterized by persistent symptoms following acute infection. Affecting tens […]
Understanding metformin use and Long COVID and ME/CFS
RECOVER researchers shared how the prescription drug metformin may reduce the risk of Long COVID and presented research examining the risk of developing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) after a […]
Long COVID trajectories in the RECOVER-Adult US cohort
Tanayott Thaweethai, Sarah E. Donohue, , et. al. Nature Communications volume 16, Article number: 9557 (2025) Abstract Longitudinal trajectories of Long COVID remain ill-defined, yet are critically needed to advance clinical trials, patient care, and public health […]
Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort
Nature Communications volume 16, Article number: 9557 (2025) Abstract Longitudinal trajectories of Long COVID remain ill-defined, yet are critically needed to advance clinical trials, patient care, and public health initiatives for millions of individuals with […]
The Problem Of Fake Science
Authored by Jeffrey Tucker via The Epoch Times, Last week, I was able to generate from artificial intelligence a fake study that proved that eating waffles increases baldness. It was […]
Data-driven RECOVER research produces new discoveries about Long COVID.
This installment of the RECOVER Research Update—a summary of recent findings published every 3 months—focuses on innovative research using patient information contained in electronic health records (EHRs). Each time a person […]
Therapeutic Strategies and Clinical Trials in Long COVID: Anticoagulants, Fibrinolytics, Endothelial Support, Immunomodulators, and RECOVER Protocols
Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is a chronic multisystem condition affecting millions globally. Despite its prevalence, therapeutic options […]